A prescriber is considering pharmacogenetic testing (PGx) for a medication even though no alternative therapy exists. What issues should the nurse discuss with the prescriber?
Select all that apply.
Note: Credit will be given only if all correct choices and no incorrect choices are selected.
◦ If the test reveals the client to be a nonresponder, is it ethical to prescribe the medication anyway?
◦ If the test inaccurately categorizes the client as a nonresponder and the medication is not prescribed, what are the implications?
◦ If the client is sensitive to the drug and will experience adverse effects, should dosing be decreased?
◦ If the client is a nonresponder to the medication, should that information be revealed to the client?
◦ If the client is prescribed this medication, what follow-up schedule is necessary?